Eli Lilly's Alzheimer's drug approved in Japan

Eli Lilly (LLY.N)said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing patients with another treatment option after Eisai (4523.T) and Biogen's (BIIB.O) Leqembi received the nod in September last year.